China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of a Supportive-Expressive Group Intervention Integrating Character Strengths on Ambivalence over Emotional Expression in Young and Middle-Aged Patients with Breast Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136485

Registration Time: 2026/11/11

Type: Interventional study

Primary Sponsor: The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349067

Published by HT Digital Content Services with permission from Health Daily Digest....